Caltex Australia Limited (ASX: CTX) updates on the margin


In respect of CRM sales from production for the month of June 2018, the company advises its realized lagged Caltex Refiner Margin (CRM). The unlagged CRM for June was US $8.63 bbl which is below the prior month figure of US$12.02 / bbl. The unlagged Caltex Singapore Weighted Average Margin for June was US$11.00 / bbl, which is below the prior month US$11.93 / bbl and below the prior year comparative figure of US $12.36 / bbl. Brent crude oil prices drove a favorable US$0.38/bbl pricing lag.

Included in the unaudited 2018 Half Year Profit Guidance released on 12 June 2018 due to lower actual refiner margins in the second half of June 2018, the June 2018 realized CRM was indicated to be below the forecast CRM of US$12.00/bbl, with higher crude premiums relating to a late June cargo, and lower yield due to a trip of the FCCU unit in the second half of June 2018.

The company stock was trading at a market price of $32.12 with a daily price change of $0.110 or a percentage change of 0.344%.

[pluginops_form template_id=’23834′ ]


Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report